Evaluation of Safety and Efficacy of PDP-716
Public ClinicalTrials.gov record NCT03450629. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Multi-Center, Investigator-Masked, Parallel Group, Equivalence Study of Once Daily Brimonidine Tartrate Ophthalmic Suspension Compared With Three Times Daily ALPHAGAN-P® in Subjects With Open Angle Glaucoma, or Ocular Hypertension
Study identification
- NCT ID
- NCT03450629
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Sun Pharma Advanced Research Company Limited
- Industry
- Enrollment
- 682 participants
Conditions and interventions
Conditions
Interventions
- Brimonidine Tartrate Ophthalmic Suspension Drug
- Brimonidine Tartrate Ophthalmic Solution Drug
Drug
Eligibility (public fields only)
- Age range
- 2 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 12, 2018
- Primary completion
- Nov 30, 2020
- Completion
- Nov 30, 2020
- Last update posted
- Feb 14, 2022
2018 – 2020
United States locations
- U.S. sites
- 47
- U.S. states
- 17
- U.S. cities
- 40
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| SPARC Site 4 | Chandler | Arizona | 85225 | — |
| SPARC Site 5 | Prescott | Arizona | 86301 | — |
| SPARC Site 3 | Sun City | Arizona | 85351 | — |
| SPARC Site 38 | Burbank | California | 91506 | — |
| SPARC Site 44 | Glendale | California | 91204 | — |
| SPARC Site 45 | Glendale | California | 91204 | — |
| SPARC Site 43 | Mission Hills | California | 91345 | — |
| SPARC Site 1 | Newport Beach | California | 92663 | — |
| SPARC Site 14 | Santa Barbara | California | 93110 | — |
| SPARC Site 47 | Torrance | California | 90505 | — |
| SPARC Site 7 | Colorado Springs | Colorado | 80919 | — |
| SPARC Site 11 | Coral Springs | Florida | 33067 | — |
| SPARC Site 29 | Deerfield Beach | Florida | 33064 | — |
| SPARC Site 34 | Fort Myers | Florida | 33901 | — |
| SPARC Site 46 | Hollywood | Florida | 33021 | — |
| SPARC Site 21 | Jacksonville | Florida | 32204 | — |
| SPARC Site 35 | Miami | Florida | 33126 | — |
| SPARC Site 27 | Miami | Florida | 33134 | — |
| SPARC Site 10 | Miami | Florida | 33143 | — |
| SPARC Site 16 | Miami | Florida | 33145 | — |
| SPARC Site 19 | Miami | Florida | 33174 | — |
| SPARC Site 25 | Miami | Florida | 33175 | — |
| SPARC Site 41 | Pompano Beach | Florida | 33060 | — |
| SPARC Site 18 | Tampa | Florida | 33603 | — |
| SPARC Site 42 | Atlanta | Georgia | 30349 | — |
| SPARC Site 2 | Morrow | Georgia | 30260 | — |
| SPARC Site 22 | Roswell | Georgia | 30076 | — |
| SPARC Site 12 | Chicago | Illinois | 60619 | — |
| SPARC Site 23 | Paducah | Kentucky | 42001 | — |
| SPARC Site 40 | Bowie | Maryland | 20715 | — |
| SPARC Site 28 | Kansas City | Missouri | 64055 | — |
| SPARC Site 48 | Kansas City | Missouri | 64133 | — |
| SPARC Site 31 | St Louis | Missouri | 63128 | — |
| SPARC Site 15 | Poughkeepsie | New York | 12603 | — |
| SPARC Site 36 | Rochester | New York | 14618 | — |
| SPARC Site 30 | Gastonia | North Carolina | 28054 | — |
| SPARC Site 9 | High Point | North Carolina | 27262 | — |
| SPARC Site 17 | Winston-Salem | North Carolina | 27101 | — |
| SPARC Site 33 | Fargo | North Dakota | 58103 | — |
| SPARC Site 37 | Cincinnati | Ohio | 45242 | — |
| SPARC Site 8 | Cleveland | Ohio | 44115 | — |
| SPARC Site 24 | Cranberry Township | Pennsylvania | 16066 | — |
| SPARC Site 32 | Memphis | Tennessee | 38119 | — |
| SPARC Site 39 | Houston | Texas | 77008 | — |
| SPARC Site 13 | Mission | Texas | 78572 | — |
| SPARC Site 20 | San Antonio | Texas | 78215 | — |
| SPARC Site 26 | Saint Albans | Vermont | 05478 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03450629, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 14, 2022 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03450629 live on ClinicalTrials.gov.